Clinical Feed
Evaluation of Blood Loss After Cesarean Delivery Via US Compared to Standard Care
RECRUITING · INTERVENTIONAL · PREVENTION study · Postpartum Period · Enrollment 276 · Sponsor: Holy Family Hospital, Nazareth, Israel
- Published: 13 Apr 2026, 12:00 pm (UTC)
- Updated: 13 Apr 2026, 12:00 pm (UTC)
- Specialty: Infectious Disease
- Source: ClinicalTrials.gov
- DOI: NCT06963047
GIST
RECRUITING · INTERVENTIONAL · PREVENTION study · Postpartum Period · Enrollment 276 · Sponsor: Holy Family Hospital, Nazareth, Israel
Clinical Editorial
Official title: Ultrasound Use Compared With Standard Care for Diagnosis of Blood Loss After Cesarean Delivery: A Randomized Controlled Trial Summary: Postpartum hemorrhage and anemia are considered a major health concern due to their impact on maternal morbidity and mortality, quality of life, and maternal cognitive and emotional functioning after delivery, which are particularly important during the critical period of mother-child bonding. Hemoglobin levels in the first 24 hours after delivery do not reflect the lowest point (nadir). The postpartum nadir occurs 48-72 hours after delivery due to the initial redistribution of plasma volume. The aim of this study was to examine whether postpartum ultrasound examination precedes laboratory test results in the diagnosis of anemia due to blood loss after cesarean section. Conditions: Postpartum Period Keywords: Postpartum anemia, Postpartum hemorrhage, Ultrasound, Cesarean section, Intra-abdominal bleeding Study type: INTERVENTIONAL Primary purpose: PREVENTION Phases: NA Enrollment: 276 (ESTIMATED) Status: RECRUITING Completion: 2026-06-01 (ESTIMATED)
Original source: https://clinicaltrials.gov/study/NCT06963047